Share Price | Westlake Chemical Partners LP Stock Analysis & Recommendation

Q: How big is Westlake Chemical Partners LP?

Market Cap: As of Jun 18, Westlake Chemical Partners LP has a market capitalization of 778.07 million, categorizing it as a Micro Cap company.Recent Quarterly Performance: For the latest four quarters, Westlake Chemical Partners LP reported net sales of 1,088.86 million and a net profit of 321.83 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 518.70 million and total assets of 1,287.96 million.

Q: What does Westlake Chemical Partners LP do?

Overview: Westlake Chemical Partners LP operates in the specialty chemicals industry and is categorized as a micro-cap company.Financial Snapshot: Most recent Net Sales: 238 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 42 Million (Quarterly Results - Mar 2025) Market-cap: USD 778.07 Million (Micro Cap)Key Metrics: P/E: 2.00 Debt Equity: 0.69 Return on Equity: 63.47% Price to Book: 1.53 Contact Details: Not available.

Q: Is Westlake Chemical Partners LP technically bullish or bearish?

As of 4 September 2025, the technical trend for Westlake Chemical Partners LP has changed from mildly bearish to bearish. The current stance is bearish with a weak strength indicated by the MACD and Bollinger Bands both showing bearish signals on both weekly and monthly time frames. The daily moving averages also confirm a bearish outlook. The KST presents a mildly bullish signal on the weekly but is mildly bearish on the monthly, while Dow Theory indicates a mildly bearish stance across both time frames. The stock has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -7.22% compared to the S&P 500's 12.22%.

Q: Is Westlake Chemical Partners LP overvalued or undervalued?

As of 31 October 2025, the valuation grade for Westlake Chemical Partners LP has moved from fair to attractive, indicating a more favorable assessment of its value. The company appears undervalued, with a P/E ratio of 2, significantly lower than its peers such as Kronos Worldwide, Inc. with a P/E of 10.01, and Advansix, Inc. at 8.36. Additionally, Westlake's EV to EBITDA ratio stands at 2.50, which is competitive compared to the industry average, suggesting potential for growth.In terms of performance metrics, Westlake boasts a robust ROE of 63.47% and an impressive ROCE of 39.90%, highlighting its efficient use of equity and capital. However, the company's stock has underperformed relative to the S&P 500, with a year-to-date return of -20.05% compared to the index's 16.30%. This disparity reinforces the notion that the stock may be undervalued, presenting a potential buying opportunity for investors.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

35.25 k

Shareholding (Dec 2025)

FII

1.60%

Held by 6 FIIs

DII

71.25%

Held by 28 DIIs

Promoter

0.45%

How big is Westlake Chemical Partners LP?

22-Jun-2025

As of Jun 18, Westlake Chemical Partners LP has a market capitalization of 778.07 million, with net sales of 1,088.86 million and a net profit of 321.83 million over the latest four quarters.

View full answer

What does Westlake Chemical Partners LP do?

22-Jun-2025

Westlake Chemical Partners LP is a micro-cap company in the specialty chemicals industry, reporting net sales of $238 million and a net profit of $42 million as of March 2025. Key financial metrics include a P/E ratio of 2.00 and a return on equity of 63.47%.

View full answer

Is Westlake Chemical Partners LP technically bullish or bearish?

20-Sep-2025

As of September 4, 2025, Westlake Chemical Partners LP is in a bearish trend with weak strength indicators, as shown by the MACD and Bollinger Bands, and has underperformed the S&P 500 with a year-to-date return of -7.22%.

View full answer

Is Westlake Chemical Partners LP overvalued or undervalued?

05-Nov-2025

As of October 31, 2025, Westlake Chemical Partners LP is considered undervalued with an attractive valuation grade, a low P/E ratio of 2 compared to peers, strong performance metrics like a 63.47% ROE, and a potential buying opportunity despite a year-to-date stock underperformance of -20.05% relative to the S&P 500's 16.30% return.

View full answer

Compare Westlake Chemical Partners LP with Similar Stocks

TETRA Technologies, Inc.Advansix, Inc.Koppers Holdings, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

High Management Efficiency with a high ROCE of 41.50%

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.74 times

Poor long term growth as Operating profit has grown by an annual rate -1.43% of over the last 5 years

The company declared very negative results in Mar'25 after flat results in Dec'24

With ROCE of 39.90%, it has a very attractive valuation with a 1.32 Enterprise value to Capital Employed

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Specialty Chemicals

Market cap

USD 776 Million (Micro Cap)

P/E

3.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.72

Return on Equity

59.96%

Price to Book

1.54

Revenue and Profits:

Net Sales:

323 Million

(Quarterly Results - Dec 2025)

Net Profit:

84 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

13.72%

6 Months

2.7%

1 Year

-5.61%

2 Years

-1.87%

3 Years

2.23%

4 Years

-15.39%

5 Years

-10.04%

Westlake Chemical Partners LP for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

2.77%

EBIT Growth (5y)

-2.61%

EBIT to Interest (avg)

25.44

Debt to EBITDA (avg)

0.74

Net Debt to Equity (avg)

0.69

Sales to Capital Employed (avg)

1.28

Tax Ratio

0.23%

Dividend Payout Ratio

106.48%

Pledged Shares

Institutional Holding

32.20%

ROCE (avg)

41.50%

ROE (avg)

66.20%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.54

EV to EBIT

3.54

EV to EBITDA

2.57

EV to Capital Employed

1.32

EV to Sales

1.00

PEG Ratio

Dividend Yield

ROCE (Latest)

37.21%

ROE (Latest)

59.96%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 7 Schemes (26.71%)

Foreign Institutions

Held by 6 Foreign Institutions (1.6%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 4.56% vs 3.97% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -2.20% vs 0.47% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "323.00",
          "val2": "308.90",
          "chgp": "4.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "124.30",
          "val2": "125.90",
          "chgp": "-1.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.50",
          "val2": "5.90",
          "chgp": "-6.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "84.30",
          "val2": "86.20",
          "chgp": "-2.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "277.80%",
          "val2": "297.80%",
          "chgp": "-2.00%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 2.71% vs -4.61% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -19.12% vs 10.34% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,166.70",
          "val2": "1,135.90",
          "chgp": "2.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "447.60",
          "val2": "502.30",
          "chgp": "-10.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "22.90",
          "val2": "25.70",
          "chgp": "-10.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "298.60",
          "val2": "369.20",
          "chgp": "-19.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "273.90%",
          "val2": "343.70%",
          "chgp": "-6.98%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

323.00

308.90

4.56%

Operating Profit (PBDIT) excl Other Income

124.30

125.90

-1.27%

Interest

5.50

5.90

-6.78%

Exceptional Items

0.00

Consolidate Net Profit

84.30

86.20

-2.20%

Operating Profit Margin (Excl OI)

277.80%

297.80%

-2.00%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 4.56% vs 3.97% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -2.20% vs 0.47% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,166.70

1,135.90

2.71%

Operating Profit (PBDIT) excl Other Income

447.60

502.30

-10.89%

Interest

22.90

25.70

-10.89%

Exceptional Items

0.00

Consolidate Net Profit

298.60

369.20

-19.12%

Operating Profit Margin (Excl OI)

273.90%

343.70%

-6.98%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 2.71% vs -4.61% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -19.12% vs 10.34% in Dec 2024

All Annual Results

Company CV

About Westlake Chemical Partners LP

Westlake Chemical Partners LP

Specialty Chemicals

No Details Available.

Company Coordinates

No Company Details Available